MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. increased its stake in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) by 89.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 112,817 shares of the company’s stock after purchasing an additional 53,213 shares during the quarter. Russell Investments Group Ltd. owned 0.23% of MeiraGTx worth $583,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Barclays PLC lifted its holdings in shares of MeiraGTx by 11.6% during the first quarter. Barclays PLC now owns 82,504 shares of the company’s stock worth $426,000 after purchasing an additional 8,568 shares during the period. DAVENPORT & Co LLC raised its position in MeiraGTx by 39.2% in the first quarter. DAVENPORT & Co LLC now owns 55,000 shares of the company’s stock worth $284,000 after acquiring an additional 15,500 shares in the last quarter. Alliancebernstein L.P. raised its position in MeiraGTx by 6.8% in the fourth quarter. Alliancebernstein L.P. now owns 36,200 shares of the company’s stock worth $236,000 after acquiring an additional 2,300 shares in the last quarter. Silverarc Capital Management LLC raised its position in MeiraGTx by 2.4% in the fourth quarter. Silverarc Capital Management LLC now owns 56,672 shares of the company’s stock worth $370,000 after acquiring an additional 1,330 shares in the last quarter. Finally, Morgan Stanley raised its position in MeiraGTx by 52.4% in the fourth quarter. Morgan Stanley now owns 90,479 shares of the company’s stock worth $590,000 after acquiring an additional 31,127 shares in the last quarter. 64.84% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Piper Sandler cut their price objective on MeiraGTx from $26.00 to $25.00 in a research report on Friday, May 12th. Chardan Capital restated a “buy” rating and issued a $41.00 price target on shares of MeiraGTx in a research report on Friday, August 11th. Finally, Royal Bank of Canada dropped their price target on MeiraGTx from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Friday, August 11th.

MeiraGTx Trading Up 1.3 %

MeiraGTx stock opened at $6.37 on Friday. The stock has a market cap of $379.21 million, a PE ratio of -2.49 and a beta of 1.36. The stock has a 50-day moving average price of $6.38 and a 200 day moving average price of $6.47. MeiraGTx Holdings plc has a 52 week low of $4.77 and a 52 week high of $9.49. The company has a current ratio of 1.99, a quick ratio of 1.99 and a debt-to-equity ratio of 0.70.

MeiraGTx (NASDAQ:MGTX) last posted its quarterly earnings data on Thursday, August 10th. The company reported ($0.53) EPS for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.06. The company had revenue of $3.54 million for the quarter, compared to analysts’ expectations of $6.33 million. Equities research analysts predict that MeiraGTx Holdings plc will post -2.32 earnings per share for the current fiscal year.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.